Ignite Creation Date:
2025-12-24 @ 9:56 PM
Ignite Modification Date:
2026-01-06 @ 9:01 AM
Study NCT ID:
NCT05239832
Status:
UNKNOWN
Last Update Posted:
2022-03-03
First Post:
2022-02-10
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
Recombinant SARS-CoV-2 Fusion Protein Vaccine Booster Immunization Study to Evaluate the Safety and Immunogencity
Sponsor:
Livzon Pharmaceutical Group Inc.
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
V-01-Booster-01
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None